1. Home
  2. ADVM vs GIFT Comparison

ADVM vs GIFT Comparison

Compare ADVM & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • GIFT
  • Stock Information
  • Founded
  • ADVM 2006
  • GIFT 1999
  • Country
  • ADVM United States
  • GIFT United States
  • Employees
  • ADVM N/A
  • GIFT N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • GIFT Catalog/Specialty Distribution
  • Sector
  • ADVM Health Care
  • GIFT Consumer Discretionary
  • Exchange
  • ADVM Nasdaq
  • GIFT Nasdaq
  • Market Cap
  • ADVM 47.4M
  • GIFT 51.0M
  • IPO Year
  • ADVM 2014
  • GIFT N/A
  • Fundamental
  • Price
  • ADVM $2.39
  • GIFT $1.36
  • Analyst Decision
  • ADVM Strong Buy
  • GIFT Strong Buy
  • Analyst Count
  • ADVM 5
  • GIFT 1
  • Target Price
  • ADVM $23.80
  • GIFT $4.00
  • AVG Volume (30 Days)
  • ADVM 338.5K
  • GIFT 98.4K
  • Earning Date
  • ADVM 08-11-2025
  • GIFT 08-15-2025
  • Dividend Yield
  • ADVM N/A
  • GIFT N/A
  • EPS Growth
  • ADVM N/A
  • GIFT N/A
  • EPS
  • ADVM N/A
  • GIFT N/A
  • Revenue
  • ADVM $1,000,000.00
  • GIFT $89,689,155.00
  • Revenue This Year
  • ADVM N/A
  • GIFT $12.22
  • Revenue Next Year
  • ADVM $18.82
  • GIFT N/A
  • P/E Ratio
  • ADVM N/A
  • GIFT N/A
  • Revenue Growth
  • ADVM N/A
  • GIFT 6.13
  • 52 Week Low
  • ADVM $1.78
  • GIFT $0.50
  • 52 Week High
  • ADVM $10.14
  • GIFT $4.22
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 44.75
  • GIFT N/A
  • Support Level
  • ADVM $2.11
  • GIFT N/A
  • Resistance Level
  • ADVM $2.60
  • GIFT N/A
  • Average True Range (ATR)
  • ADVM 0.22
  • GIFT 0.00
  • MACD
  • ADVM -0.00
  • GIFT 0.00
  • Stochastic Oscillator
  • ADVM 36.39
  • GIFT 0.00

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About GIFT RDE Inc. Common Stock

Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.

Share on Social Networks: